Sign inGet started
Dataset · Hugging Face

Tc-43/Nav1.7_VSD4_NonAnionic_Designs_8I5G

Nav1.7 VSD4 Non-Anionic Designs — 8I5G (GA-II) Why this target matters. Human genetics validates Nav1.7 as thoroughly as any pain target in existence — loss-of-function carriers are congenitally insensitive to pain, gain-of-function mutations cause erythromelalgia — yet no Nav1.7 blocker has reached approval, and the clinical failures of the aryl sulfonamide class are widely attributed to the properties that come with its anionic warhead. 459 small molecules generated de novo… See the full description on the dataset page: https://huggingface.co/datasets/Tc-43/Nav1.7_VSD4_NonAnionic_Designs_8I5

Author / organizationTc-43
License (as declared)cc-by-4.0
Downloads199 (as reported by Hugging Face)
Likes0
Created16 September 2026
Last updated at source16 September 2026
chemistrybiologydrug-discoverymolecular-dockingprotein-ligand-complexpocket-conditionedpocket-conditioned-generationde-novo-designde-novo-drug-designgenerative-designgenerative-aiai-generatedstructure-based-drug-designcomputational-chemistrycheminformaticsSMILESSDFNav1.7SCN9Asodium-channelion-channelVSD4voltage-sensing-domainanalgesia
Embed this entry
<iframe src="https://silytics.si/embed/item/cc2b3c6f-ebf7-497b-ad96-38734c1c9d81" width="420" height="190" style="border:0" loading="lazy" title="Silytics entry"></iframe>

Free, no tracking. More about feeds and embeds.

Popularity, last 2 days

199 now (-17 since 2026-10-16). Counts as reported by the source, snapshotted daily by Silytics.

More from Tc-43

Silytics shows public metadata from Hugging Face and links to the original. Information may be incomplete or out of date. Last refreshed 17 October 2026. Licenses and terms of the original apply to the work itself. Not financial, legal or professional advice.